Gillian Carling, PhD
@carlinggillian
Senior Scientist at @Pfizer
@WeillCornell '24
@Columbia '17
ID: 1258520417318379520
07-05-2020 22:13:51
18 Tweet
45 Followers
44 Following
Our new study out today in Science Translational Medicine identifies a TREM2 R47H-specific microglial subpopulation in human AD brain and tauopathy mice, reminiscent of DAM and AKT hyperactivation which can be rescued by pharmacological AKT inhibition. science.org/doi/10.1126/sc…
Our collaborative work with Martin Kampmann is out today in Nature Neuroscience! We devised a fast and efficient method to generate induced #microglia from #iPSCs and developed #CRISPR i/a platforms to study regulators of microglial states in health and disease. nature.com/articles/s4159…
🎉🎉Congratulations to Gillian Carling, PhD, who received the NoA for her F31! So excited for your innovative research on the TREM2-APOE pathway to be recognized! Way to go! 🥳
Friend turned foe? Our insight article commenting on the exciting work from David Holtzman about TREM2 agonist antibody exacerbates tau seeding in 5xFAD mice (Jain et al. JEM), pointing at the importance of timing for TREM2 agonist antibodies in treating AD. rupress.org/jem/article/22…
Our latest study is out today in Nature Neuroscience. We report that tau-activation of cGAS in AD diminishes cognitive resilience by decreasing the neuronal transcriptional network of MEF2C through type I interferon (IFN-I) signaling. (1/6) nature.com/articles/s4159…
Super excited to announce our latest work in Molecular Neurodegeneration! We generated new anti-acetylated-tau-K174 antibodies that effectively mitigate neurobehavioral impairments and reduce pathology in PS19 mice— alone and in conjunction with TBI. (1/5) Details here: bit.ly/4bbKokA
Congratulations, Dr. Gillian Carling! Yesterday Dr. Carling successfully defended her thesis on the combined role of TREM2 and APOE4 in cGAS-associated senescence and neurodegeneration in AD. Your hard work these past 5 years has paid off, Dr. Carling!🥳 Gillian Carling, PhD WCM Brain and Mind Research Institute
Drs. Gillian Carling, PhD, Li Gan, et al. Weill Cornell Medicine found that two genetic variants, that confer high risk of #Alzheimers, together trigger harmful inflammatory response in brain’s immune cells, particularly in females, in preclinical model Neuron cell.com/neuron/fulltex…